AzTrials
AzTrials

Maternal HealthMobile WAChNCT01894126

Mobile Phone Messaging to Improve Women's and Children's Health (Mobile WACh) in Kenya

A study testing Two-way SMS Dialogue and One-way SMS Messaging in people with Maternal Health and Neonatal Health, run by University of Washington at 1 site in Kenya.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

With the increased prevalence of cellular phones, mobile technology provides an important tool to reach underserved populations in low to middle income countries. mHealth interventions offer promise to improve maternal child health throughout the reproductive health continuum if they contribute to increasing skilled… Read more about this study

Who is it for?
Ages 14 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Maternal Health, Neonatal Health, Family Planning
What is being tested?
Two-way SMS Dialogue and One-way SMS Messaging
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteKenya
Study dates
Jul 2013to Jul 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 years and older
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Pregnant
  • Access to a mobile phone
  • Able to read SMS messages
  • Willing to receive SMS messages

Who cannot join

  • Unwilling or unable to meet inclusion criteria

Trial locations and contacts

1 site in 1 country.

Kenya1 site

  • Mathare North Health Centre

    Nairobi

Other trials in Kenya

About this study

Official title: Mobile Phone One Way Short Message Service (SMS) Versus SMS Dialogue for Women's and Child Health (Mobile WACh) in Kenya: A Randomized Control Trial

With the increased prevalence of cellular phones, mobile technology provides an important tool to reach underserved populations in low to middle income countries. mHealth interventions offer promise to improve maternal child health throughout the reproductive health continuum if they contribute to increasing skilled birth attendance, family planning and exclusive breastfeeding. We propose a randomized clinical trial to determine effect of using mobile phones to deliver SMS (one-way) versus an interactive SMS dialogue (two-way) on uptake of reproductive and neonatal health services and maternal and infant outcomes

Being tested
Two-way SMS Dialogue, One-way SMS Messaging

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Two-way SMS DialogueBehavioural

  • One-way SMS MessagingBehavioural

Study groups in NCT01894126
Study groupRoleWhat they receive
Two-way SMS dialogueExperimentalWomen will receive SMS messages with prompts to reply. They will have the ability to text back to the system and both respond to and initiate SMS dialogue
Receives: Behavioral: Two-way SMS Dialogue
One-way SMS MessagingExperimentalWomen will receive scheduled one-way SMS messages
Receives: Behavioral: One-way SMS Messaging
ControlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Contraceptive uptake

    Measured: 10 weeks postpartum; 24 weeks postpartum

  2. Facility Delivery

    Measured: Postpartum

  3. Exclusive Breastfeeding

    Measured: 24 weeks postpartum

Secondary outcomes (4)

  1. ANC attendance

    Measured: Postpartum

  2. Infant Immunizations

    Measured: Six months postpartum

  3. Maternal mortality

    Measured: 6 months postpartum

  4. Infant mortality

    Measured: Six months postpartum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2013 (estimated)
  2. Study startJul 2013
  3. Primary completionJul 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01894126
Sponsor's protocol ID
K12HD001264-14UNGER
Other IDs
K12HD001264-14
Acronym
Mobile WACh
Status last verified
Nov 2016
First submitted
2 Jul 2013
Last updated
9 Nov 2016
Results posted
No
Data monitoring committee
No

Publications

  • Palmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679.

    PubMed 32813276

Questions about this trial

What is this clinical trial studying?

A study testing Two-way SMS Dialogue and One-way SMS Messaging in people with Maternal Health and Neonatal Health, run by University of Washington at 1 site in Kenya.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Kenya. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Contraceptive uptake (time frame: 10 weeks postpartum; 24 weeks postpartum). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01894126, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2016; AzTrials last refreshed its copy on 8 Nov 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in